Franziska Bachhuber

Albert Einstein Allee 11
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Kappa Free Light Chain for Diagnosis and Neurofilament Light Chain for Prognosis in Autoimmune Encephalitis.

Kappa Free Light Chain for Diagnosis and Neurofilament Light Chain for Prognosis in Autoimmune Encephalitis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 03, 2026

Bi-compartmental CSF-serum analysis of NfL and GFAP differentiates central and peripheral pathology in neuroinfectious diseases: A monocentric real-world cohort study.

Bi-compartmental CSF-serum analysis of NfL and GFAP differentiates central and peripheral pathology in neuroinfectious diseases: A monocentric real-world cohort study.

Journal: Neurobiology of disease

Published: June 09, 2026

Distinct cerebrospinal fluid profiles of astrocytic aquaporin-4 and GFAP in neuroinflammatory disorders.

Distinct cerebrospinal fluid profiles of astrocytic aquaporin-4 and GFAP in neuroinflammatory disorders.

Journal: Neurobiology of disease

Published: January 12, 2026

Divergent Immunological and Neurotrophic Responses to CD20 Depletion in Relapsing and Progressive Multiple Sclerosis.

Divergent Immunological and Neurotrophic Responses to CD20 Depletion in Relapsing and Progressive Multiple Sclerosis.

Journal: Neurology and therapy

Published: December 18, 2025

Cognition and fatigue in clinically stable multiple sclerosis: EDSS and MRI metrics outperform serum biomarkers.

Cognition and fatigue in clinically stable multiple sclerosis: EDSS and MRI metrics outperform serum biomarkers.

Journal: BMC neurology

Published: December 05, 2025

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis.

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis.

Journal: European journal of neurology

Published: August 31, 2025

Increased transmembrane protein 119 (TMEM119) levels in the cerebrospinal fluid of patients with mild cognitive impairment due to Alzheimer's disease suggest early microglial involvement.

Increased transmembrane protein 119 (TMEM119) levels in the cerebrospinal fluid of patients with mild cognitive impairment due to Alzheimer's disease suggest early microglial involvement.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: July 12, 2025

Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora Disease.

Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora Disease.

Journal: Neurology. Genetics

Published: June 02, 2025

Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases.

Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases.

Journal: Journal of neurology

Published: June 01, 2025

Age-Specific Control and Alzheimer Disease Reference Curves and z-Scores for Glial Fibrillary Acidic Protein in Blood.

Age-Specific Control and Alzheimer Disease Reference Curves and z-Scores for Glial Fibrillary Acidic Protein in Blood.

Journal: Clinical chemistry

Published: April 17, 2025

Correction: Clinical characterization of common pathogenic variants of SOD1-ALS in Germany.

Correction: Clinical characterization of common pathogenic variants of SOD1-ALS in Germany.

Journal: Journal of neurology

Published: March 08, 2025

Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using an in-house assay for the detection of neurofilament medium chain.

Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using an in-house assay for the detection of neurofilament medium chain.

Journal: EBioMedicine

Published: March 08, 2025

Showing 1-12 of 32

Last Updated: 09/26/2026